-
1
المؤلفون: Guido E.L. van den Berk, Mark G. J. de Boer, Willemien Dorama, Kees Brinkman, Daoud Ait Moha, Natasja van Holten, Josephine E. Oryszcyn
المصدر: AIDS, 30(18), 2831-2834
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Pyridones, 030106 microbiology, Immunology, HIV Infections, Piperazines, Medication Adherence, Cohort Studies, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Abacavir, Antiretroviral Therapy, Highly Active, Internal medicine, Oxazines, Product Surveillance, Postmarketing, Humans, Immunology and Allergy, Medicine, 030212 general & internal medicine, Aged, Netherlands, Aged, 80 and over, Sleep disorder, business.industry, integrase inhibitor, toxicity, Middle Aged, medicine.disease, Confidence interval, Discontinuation, dolutegravir, Regimen, side effects, Infectious Diseases, Anti-Retroviral Agents, Withholding Treatment, chemistry, Relative risk, Dolutegravir, Female, business, Heterocyclic Compounds, 3-Ring, Cohort study, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7afd65f94cd40c4f10ec82a622eb1177
https://hdl.handle.net/1887/112105